Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
- Conditions
- Hematological MalignancyMetastatic Cancer
- Interventions
- Other: CAPRI
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 1000
- Registration Number
- NCT02828462
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Phase 1
Recruiting
- Conditions
- Pediatric Cancer
- Interventions
- First Posted Date
- 2016-06-24
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 455
- Registration Number
- NCT02813135
- Locations
- 🇫🇷
CHU Angers, Angers, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷CHU Pellegrin, Bordeaux, France
Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 600
- Registration Number
- NCT02679963
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus, Villejuif, Val de Marne, France
Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2018-08-16
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 103
- Registration Number
- NCT02672527
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction
Phase 2
- Conditions
- Breast Cancer
- Interventions
- Procedure: MastectomyDevice: Da Vinci Robot Xi
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 80
- Registration Number
- NCT02673268
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus, Villejuif, Val de Marne, France
Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
Not Applicable
- Conditions
- Metastatic Cancer
- Interventions
- Procedure: Blood samples
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 2240
- Registration Number
- NCT02666612
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank
- Conditions
- Paediatric Malignancies
- Interventions
- Procedure: saliva samplesProcedure: blood samples
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 6000
- Registration Number
- NCT02666625
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast
Not Applicable
Completed
- Conditions
- Kidney Metastatic CancerRectal Metastatic CancerBreast Metastatic CancerColon Metastatic CancerGIST Metastatic Cancer
- Interventions
- Device: CEUS (Contrast-enhanced ultrasound)
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 59
- Registration Number
- NCT02666690
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France
Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling
Not Applicable
- Conditions
- Relapsed or Refractory Pediatric Tumor
- Interventions
- Procedure: biopsy or surgical resection of tumor and blood sampling
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 700
- Registration Number
- NCT02613962
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
🇪🇸Hospital Universitari Vall D'Hebron, Barcelona, Cataluna, Spain
🇮🇹Fondazione IRCCS Istituto, Milano, Italy
Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: BiopsyProcedure: Blood sample
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 300
- Registration Number
- NCT02523612
- Locations
- 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France
© Copyright 2025. All Rights Reserved by MedPath